These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12788138)

  • 1. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in children.
    Mimouni KF; Bressler SB; Bressler NM
    Am J Ophthalmol; 2003 Jun; 135(6):900-2. PubMed ID: 12788138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series.
    Saperstein DA; Rosenfeld PJ; Bressler NM; Rosa RH; Sickenberg M; Sternberg P; Aaberg TM; Aaberg TM; Reaves TA;
    Ophthalmology; 2002 Aug; 109(8):1499-505. PubMed ID: 12153802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
    Bressler NM;
    Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.
    Miller JW; Schmidt-Erfurth U; Sickenberg M; Pournaras CJ; Laqua H; Barbazetto I; Zografos L; Piguet B; Donati G; Lane AM; Birngruber R; van den Berg H; Strong A; Manjuris U; Gray T; Fsadni M; Bressler NM; Gragoudas ES
    Arch Ophthalmol; 1999 Sep; 117(9):1161-73. PubMed ID: 10496388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.
    Bressler NM; Arnold J; Benchaboune M; Blumenkranz MS; Fish GE; Gragoudas ES; Lewis H; Schmidt-Erfurth U; Slakter JS; Bressler SB; Manos K; Hao Y; Hayes L; Koester J; Reaves A; Strong HA;
    Arch Ophthalmol; 2002 Nov; 120(11):1443-54. PubMed ID: 12427056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.
    Verteporfin in Photodynamic Therapy Study Group
    Ophthalmology; 2001 May; 108(5):841-52. PubMed ID: 11320011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.
    Blinder KJ; Blumenkranz MS; Bressler NM; Bressler SB; Donato G; Lewis H; Lim JI; Menchini U; Miller JW; Mones JM; Potter MJ; Pournaras C; Reaves A; Rosenfeld P; Schachat AP; Schmidt-Erfurth U; Sickenberg M; Singerman LJ; Slakter JS; Strong HA; Virgili G; Williams GA
    Ophthalmology; 2003 Apr; 110(4):667-73. PubMed ID: 12689884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes.
    Sickenberg M; Schmidt-Erfurth U; Miller JW; Pournaras CJ; Zografos L; Piguet B; Donati G; Laqua H; Barbazetto I; Gragoudas ES; Lane AM; Birngruber R; van den Bergh H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
    Arch Ophthalmol; 2000 Mar; 118(3):327-36. PubMed ID: 10721954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series.
    Chan WM; Lam DS; Wong TH; Lai TY; Kwok AK; Tam BS; Li KK
    Ophthalmology; 2003 Dec; 110(12):2395-402. PubMed ID: 14644724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks.
    Karacorlu M; Karacorlu S; Ozdemir H; Mat C
    Am J Ophthalmol; 2002 Sep; 134(3):360-6. PubMed ID: 12208247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy with verteporfin in subfoveal choroidal neovascularization secondary to central serous chorioretinopathy.
    Ergun E; Tittl M; Stur M
    Arch Ophthalmol; 2004 Jan; 122(1):37-41. PubMed ID: 14718292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in central serous chorioretinopathy: case report].
    Maia HS; Turchetti R; Zajdenweber M; Brasil OF
    Arq Bras Oftalmol; 2005; 68(4):561-4. PubMed ID: 16322848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy of subfoveal and juxtafoveal choroidal neovascularization in ocular histoplasmosis syndrome: a retrospective case series.
    Liu JC; Boldt HC; Folk JC; Gehrs KM
    Retina; 2004 Dec; 24(6):863-70. PubMed ID: 15579982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
    Azab M; Boyer DS; Bressler NM; Bressler SB; Cihelkova I; Hao Y; Immonen I; Lim JI; Menchini U; Naor J; Potter MJ; Reaves A; Rosenfeld PJ; Slakter JS; Soucek P; Strong HA; Wenkstern A; Su XY; Yang YC;
    Arch Ophthalmol; 2005 Apr; 123(4):448-57. PubMed ID: 15824216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in Vogt-Koyanagi-Harada syndrome.
    Farah ME; Costa RA; Muccioli C; Guia TA; Belfort R
    Am J Ophthalmol; 2002 Jul; 134(1):137-9. PubMed ID: 12095828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin.
    Spaide RF; Martin ML; Slakter J; Yannuzzi LA; Sorenson J; Guyer DR; Freund KB
    Am J Ophthalmol; 2002 Jul; 134(1):62-8. PubMed ID: 12095809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective case series of juxtafoveal choroidal neovascularization treated with photodynamic therapy with verteporfin.
    Blair MP; Apte RS; Miskala PH; Bressler SB; Goldberg MF; Schachat AP; Bressler NM
    Retina; 2004 Aug; 24(4):501-6. PubMed ID: 15300069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.
    Verteporfin In Photodynamic Therapy Study Group
    Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Japanese Age-Related Macular Degeneration Tial (JAT) Study Group
    Am J Ophthalmol; 2003 Dec; 136(6):1049-61. PubMed ID: 14644215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.